ARK Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-775,787	Closed	-$5.46M	–	228
2023 Q2	$5.46M	Sell	775,787 -33,179	-4%	-$237K	0.04%	123
2023 Q1	$4.94M	Sell	808,966 -10,898	-1%	-$75.2K	0.03%	124
2022 Q4	$5.24M	Sell	819,864 -1,497,353	-65%	-$11.7M	0.05%	124
2022 Q3	$22.2M	Sell	2,317,217 -618,462	-21%	-$7.13M	0.15%	80
2022 Q2	$19.8M	Sell	2,935,679 -101,764	-3%	-$1.33M	0.12%	93
2022 Q1	$50.6M	Sell	3,037,443 -4,164,075	-58%	-$64.4M	0.21%	69
2021 Q4	$137M	Sell	7,201,518 -4,448,319	-38%	-$97.9M	0.42%	46
2021 Q3	$287M	Sell	11,649,837 -6,800,876	-37%	-$160M	0.69%	36
2021 Q2	$480M	Sell	18,450,713 -1,275,937	-6%	-$33.2M	0.89%	30
2021 Q1	$625M	Buy	19,726,650 +4,428,828	+29%	+$184M	1.24%	23
2020 Q4	$710M	Buy	15,297,822 +7,394,514	+94%	+$294M	1.89%	13
2020 Q3	$260M	Buy	7,903,308 +3,668,035	+87%	+$112M	1.54%	19
2020 Q2	$116M	Buy	4,235,273 +3,348,094	+377%	+$110M	1.25%	24
2020 Q1	$26.6M	Buy	887,179 +63,835	+8%	+$1.69M	0.66%	33
2019 Q4	$22.8M	Buy	823,344 +8,548	+1%	+$194K	0.57%	38
2019 Q3	$14.8M	Buy	814,796 +7,108	+0.9%	+$157K	0.32%	50
2019 Q2	$19.8M	Buy	807,688 +116,194	+17%	+$1.75M	0.5%	40
2019 Q1	$6.58M	Sell	691,494 -34,866	-5%	-$339K	0.19%	60
2018 Q4	$6.43M	Buy	726,360 +301,540	+71%	+$2.91M	0.26%	53
2018 Q3	$4.78M	Buy	424,820 +302,197	+246%	+$4.29M	0.14%	70
2018 Q2	$1.57M	Buy	122,623 +57,527	+88%	+$841K	0.06%	95
2018 Q1	$1.1M	Buy	+65,096	New	+$986K	0.05%	100